Elias A. Rahal

Department of Experimental Pathology, American University of Beirut

Affiliated withAmerican University of Beirut

Research Area

Biography

Elias A. Rahal has not added Biography.
If you are Elias A. Rahal and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 1	2022

Other Publications

Article	Year
Role of rifampicin in limiting Escherichia coli O157:H7 Shiga-like toxin expression and enhancement of survival of infected BALB/c mice. International journal of antimicrobial agents\| PubMed ID: 21129928	2011
Decrease in Shiga toxin expression using a minimal inhibitory concentration of rifampicin followed by bactericidal gentamicin treatment enhances survival of Escherichia coli O157:H7-infected... Annals of clinical microbiology and antimicrobials\| PubMed ID: 21906403	2011
The impact of prophylactic antiviral agents and statin administration on graft longevity in kidney allograft recipients. Immunopharmacology and immunotoxicology\| PubMed ID: 22292901	2012
Escherichia coli O157:H7-Clinical aspects and novel treatment approaches. Frontiers in cellular and infection microbiology\| PubMed ID: 23162800	2012
Effects of subinhibitory concentrations of antimicrobial agents on Escherichia coli O157:H7 Shiga toxin release and role of the SOS response. Foodborne pathogens and disease\| PubMed ID: 23808851	2013
Effect of rifampicin and gentamicin on Shiga toxin 2 expression level and the SOS response in Escherichia coli O104:H4. Foodborne pathogens and disease\| PubMed ID: 25383748	2015
Approaches to treatment of emerging Shiga toxin-producing Escherichia coli infections highlighting the O104:H4 serotype. Frontiers in cellular and infection microbiology\| PubMed ID: 25853096	2015
Epstein-Barr Virus and Human herpes virus 6 Type A DNA Enhance IL-17 Production in Mice. Viral immunology\| PubMed ID: 25870901	2015
Atorvastatin Reduces the Survival of Candida albicans-Infected BALB/c Mice. Frontiers in microbiology\| PubMed ID: 26732740	2015
Epstein-Barr Virus DNA Enhances Diptericin Expression and Increases Hemocyte Numbers in via the Immune Deficiency Pathway. Frontiers in microbiology\| PubMed ID: 29942298	2018
Epstein-Barr virus DNA modulates regulatory T-cell programming in addition to enhancing interleukin-17A production via Toll-like receptor 9. PloS one\| PubMed ID: 29995930	2018
The role of viral infections in the development of autoimmune diseases. Critical reviews in microbiology\| PubMed ID: 31145640	2019
Endosomal Toll-Like Receptors Mediate Enhancement of Interleukin-17A Production Triggered by Epstein-Barr Virus DNA in Mice. Journal of virology\| PubMed ID: 31375581	2019
Atorvastatin increases the production of proinflammatory cytokines and decreases the survival of Escherichia coli-infected mice. Scientific reports\| PubMed ID: 31406240	2019
Endosomal Toll-Like Receptors (TLRs) mediate enhancement of IL-17A production triggered by Epstein-Barr virus (EBV) DNA in mice. Journal of infection in developing countries\| PubMed ID: 31805001	2018
Triple Immunotherapy Overcomes Immune Evasion by Tumor in a Melanoma Mouse Model. Frontiers in oncology\| PubMed ID: 32596146	2020
as a Model System to Assess the Effect of Epstein-Barr Virus DNA on Inflammatory Gut Diseases. Frontiers in immunology\| PubMed ID: 33828545	2021
Effect of Epstein-Barr Virus DNA on the Incidence and Severity of Arthritis in a Rheumatoid Arthritis Mouse Model. Frontiers in immunology\| PubMed ID: 34040613	2021
Epstein-Barr Virus DNA Exacerbates Colitis Symptoms in a Mouse Model of Inflammatory Bowel Disease. Viruses\| PubMed ID: 34210024	2021
IL-17A in COVID-19 Cases: a meta-analysis. Journal of infection in developing countries\| PubMed ID: 34898490	2021
Methods for fighting emerging pathogens. Nature methods\| PubMed ID: 35396474	2022
Editorial: The microbial modulation of autoimmune processes and proinflammatory pathways. Frontiers in cellular and infection microbiology\| PubMed ID: 35982782	2022